Matrine Suppresses the Migration and Invasion of NSCLC Cells by Inhibiting PAX2-Induced Epithelial-Mesenchymal Transition [Retraction]

Yang J, He D, Peng Y, et al. OncoTargets and Therapy. 2017;10:5209–5217.

The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. Following the authors request to make corrections an investigation found several images within Figures 2 and 5 appeared to have been duplicated.

• Figure 2A, A549, Migration, (0mg/mL), appears to have been duplicated with the same images for Figure 2A, A549, Migration, (0.5mg/mL); Invasion (0mg/mL); Invasion, (0.5mg/mL) and Figure 2B, H1299, Invasion, (0mg/mL).
• Figure 2A, A549, Migration, (1mg/mL), appears to have been duplicated with the same images for Figure 2A, A549, Invasion, (1mg/mL) and Figure 2B, H1299, Migration, (1mg/mL).
• Figure 5C, A459, GAPDH, appears to have been duplicated with the same image for Figure 5D, H1299, GAPDH.

The authors cooperated with the investigation and provided data associated with the study. However, despite the authors’ assistance, they were unable to provide a satisfactory explanation for how the images came to be duplicated, and the validity of the published work could not be verified. The decision was made to retract the article and the authors agreed with this.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.